Label: information for the patient
Dutasteride/Tamsulosin ratio 0.5 mg/0.4 mg hard EFG capsules
Dutasteride/hydrochloride of tamsulosin
Read this label carefully before starting to take this medicine, as it contains important information for you.
Dutasteride/Tamsulosin is used in men to treat an enlarged prostate (benign prostatic hyperplasia)- a non-cancerous growth of the prostate caused by excessive production of a hormone called dihydrotestosterone.
Dutasteride/Tamsulosinis a combination of two different medications called dutasteride and tamsulosin. Dutasteride belongs to a group of medications called 5-alpha reductase inhibitorsand tamsulosin belongs to a group of medications called alpha blockers.
As the prostate enlarges, it can produce urinary problems such as difficulty in urinating and a need to urinate more frequently. It can also cause a smaller and weaker urine stream. If benign prostatic hyperplasia is not treated, there is a risk of complete urine flow blockage (acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or remove it.
Dutasteride reduces dihydrotestosterone production, which helps to reduce prostate size and alleviate symptoms. This reduces the risk of acute urinary retention and the need for surgery. Tamsulosin acts by relaxing prostate muscles, making urination easier and rapidly improving symptoms.
Do not takeDutasteride/Tamsulosin ratio:
-if you are a woman (because this medication is only for men)
-if you are a child or adolescent under 18 years of age
-if you are allergic to dutasteride, other 5-alpha reductase inhibitors, tamsulosin, soy, peanuts, orany of the other components of this medication(listed in section 6)
-if you have low blood pressure, which makes you feel dizzy, lightheaded, or faint (orthostatic hypotension)
-if you have a severe liver disease.
If you think you have any of these situations,do not takethis medication until you have consulted with your doctor.
Warnings and precautions
Consult your doctor before starting to take dutasteride/tamsulosin.
Consult your doctor or pharmacist if you have any doubts related to taking dutasteride/tamsulosin.
Use of dutasteride/tamsulosin with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Do not take dutasteride/tamsulosin with these medications:
Do not take dutasteride/tamsulosin with these medications:
Certain medications may interact with dutasteride/tamsulosin ratio, which may cause you to experience adverse effects. Some of these medications are:
Inform your doctor if you are taking any of these medications.
Taking dutasteride/tamsulosin with food and drinks
You should take dutasteride/tamsulosin 30 minutes after the same meal every day.
Pregnancy, breastfeeding, and fertility
Women should not take dutasteride/tamsulosin ratio.
Pregnant women (or those who may be pregnant) should avoid contact with broken capsules. Dutasteride is absorbed through the skin and may affect the normal development of the male fetus. This risk is especially important in the first 16 weeks of pregnancy.
Use a condom during sexual intercourse.Dutasteride has been found in the semen of men taking dutasteride/tamsulosin.If your partner is pregnant or thinks she may be pregnant, you should avoid exposing her to your semen.
Dutasteride/tamsulosin has been shown to decrease sperm count, motility, and semen volume. This may reduce your fertility.
Consult your doctor if a pregnant woman has been in contact with dutasteride/tamsulosin.
Driving and operating machinery
Some people may experience dizziness during treatment with dutasteride/tamsulosin, which may affect your ability to drive or operate machinery safely.
Do not drive or operate machinery if you are affected in this way.
Dutasteride/Tamsulosin ratio contains lecithin from soy
This medication contains lecithin from soy. Do not use it in case of allergy to peanuts or soy.
Dutasteride/Tamsulosin ratio contains propylene glycol
This medication contains 299.46 mg of propylene glycol monocaprylate, type II in each capsule (equivalent to more than 1 mg/kg/day, but less than 50 mg/kg/day of propylene glycol) and traces of propylene glycol in the black ink.
Dutasteride/Tamsulosin ratio contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per capsule; that is, it is essentially "sodium-free".
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist.
If you do not takedutasterida/tamsulosinaregularly, the control of your PSA levels may be affected. In case of doubt, consult your doctor or pharmacist again.
What dose should you take
The recommended dose is one capsule once a day, 30 minutes after the same meal every day.
How to take it
The capsules should be swallowed whole, with water. Do not chew or break the capsules. Contact with the contents of the capsules may irritate your mouth or throat.
If you take moredutasterida/tamsulosinathan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to takedutasterida/tamsulosina
Do not take a double dose to compensate for the missed doses. Take the next dose at the usual time.
Do not interrupt the treatment ofdutasterida/tamsulosinawithout advice
Do not interrupt the treatment withdutasterida/tamsulosinawithout consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Allergic reaction
The symptoms of an allergic reaction may include:
Contact your doctor immediately if you experience any of these symptoms and stop taking this medicine.
Dizziness, lightheadedness, and fainting
Dutasteride/tamsulosin may cause dizziness, lightheadedness, and, in rare cases, fainting. You should be careful when getting up quickly after sitting or lying down, especially if you have to get up during the night, until you know how this medicine affects you. If you feel dizzy or experience lightheadedness during treatment,sit or lie down until these symptoms have disappeared.
Severe skin reactions
The signs of severe skin reactions may include:
Contact your doctor immediately if you have these symptoms and stop using this medicine.
Common side effects
These may affect up to 1 in 10 men:
*In a small number of people, some of these adverse events may continue after stopping this medicine.
These may affect up to 1 in 100 men:
Rare side effects
These may affect up to 1 in 1,000 men:
Very rare side effects
These may affect up to 1 in 10,000 men:
Other side effects
Other side effects have been reported in a reduced number of men but the exact frequency is unknown (the frequency cannot be estimated from the available data):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the bottle after CAD. The expiration date is the last day of the month indicated.
Store below 30 °C.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need.By doing so, you will help protect the environment.
Composition ofDutasteride/Tamsulosin ratio
The active ingredients are dutasteride and hydrochloride of tamsulosin.Each capsule contains0.5 mg of dutasteride (in a soft capsule) and 0.4 mg of hydrochloride of tamsulosin (as modified-release pellets).
The other components are:
Hard capsule shell:
Iron oxide black (E172)
Iron oxide red (E172)
Titanium dioxide (E171)
Iron oxide yellow (E172)
Gelatin
Black ink (shellac, iron oxide black (E172), propylene glycol, ammonium solution, concentrated potassium hydroxide.
Soft capsule content of dutasteride:
Propylene glycol monocaprylate, type II (see section 2 “Dutasteride / Tamsulosin ratio contains propylene glycol”)
Butylhydroxytoluene (E321)
Gelatin
Glycerol
Titanium dioxide (E171)
Triglycerides (medium chain)
Lecithin (may contain soy oil) (see section 2 “Dutasteride / Tamsulosin ratio contains soy lecithin”)
Content of tamsulosin pellets:
Acrylate/methacrylate copolymer (1:1) dispersion 30 percent (contains sodium lauryl sulfate and polysorbate 80,see section 2 “Dutasteride / Tamsulosin ratio contains sodium”)
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Colloidal hydrated silica
Calcium stearate
Appearance of the product and contents of the package
This medicine is presented inhard, oblong capsules with a brown body and beige cap printed with C001 in black ink of approximately 24 mm in length.
Package sizes:
HDPE bottles: 7, 30, 90, and 180 (2 bottles of 90) capsules.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11
Edificio Albatros B, 1st floor
28108 Alcobendas, Madrid (Spain)
Responsible manufacturer:
Laboratorios LEON FARMA, S.A.
Navatejera Industrial Estate
C/ La Vallina, s/n 24193 Navatejera – León
Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Netherlands:Dutasteride/Tamsulosinehydrochloride Teva 0.5 mg/0.4 mg, hard capsules
Spain:Dutasterida/Tamsulosina ratio 0.5 mg/0.4 mg hard capsules EFG
Portugal:Dutasterida + Tansulosina ratiopharm
Last review date of this leaflet:July 2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.